top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
CT Atlas of Adult Congenital Heart Disease [[electronic resource] /] / by Wojciech Mazur, Marilyn J. Siegel, Tomasz Miszalski-Jamka, Robert Pelberg
CT Atlas of Adult Congenital Heart Disease [[electronic resource] /] / by Wojciech Mazur, Marilyn J. Siegel, Tomasz Miszalski-Jamka, Robert Pelberg
Autore Mazur Wojciech
Edizione [1st ed. 2013.]
Pubbl/distr/stampa London : , : Springer London : , : Imprint : Springer, , 2013
Descrizione fisica 1 online resource (364 p.)
Disciplina 610
616.0757
616.12
616.12075
Soggetto topico Cardiology
Radiology
Imaging / Radiology
ISBN 1-4471-5088-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Foreword -- Preface -- Embryology and the Normal Heart -- Cardiac Embryology -- The Normal Heart -- Normal Anatomic Variants and Imaging Artifacts Mimicking Pathology -- Basic nomenclature and Approach to Evaluating Congenital Heart Disease Imaging -- Basic Nomenclature in Adult Congenital Heart Disease -- Systematic Approach to CT Interpretation in Adult Congenital Heart Disease -- CT Imaging Techniques in Adult Congenital Heart Disease -- Technical Principles in CT Imaging of Adult Congenital Heart Disease -- Congenital Dysplasias and Cardiomyopathies -- Arrythmogenic Right Ventricular Dysplasia -- Uhl Anomaly -- Isolated Left Ventricular Noncompaction (LVNC) -- Hyperthrophic Cardiomiopathy -- Anomalies with Normal chamber and Valve Sequence and Position -- Septal Defects -- Atrioventricular valve abnormalities -- Left ventricular outflow tract abnormalities -- Right ventricular outflow tract abnormalities -- Arterial anomalies (Excluding Coronary Anomalies) -- Coronary Anomalies -- Venous anomalies -- Anomalies with Abnormal Chamber Sequence or Relationship -- Abnormal relationship between Atria and Ventricles -- Abnormal Relationships between Ventricles and Great Vessel -- Heterotaxy syndrome -- Common Palliative and Corrective Procedures in Adult Congenital Heart Disease -- Percutaneous Closure Procedures -- Aortopulmonary Shunts -- Atrial baffles: (Mustard, Senning) -- Arterial Switch Operations -- Fontan and Kawashima procedures -- Rastelli procedure -- Damus-Kaye-Stansel procedure -- Double switch procedure -- Tetrology of Fallot repair -- Ross procedure -- Norwood procedure and Sano Modification -- Aortic Coarctation Repairs -- Congenital Pericardial Abnormalites -- Absence of the Pericardium and Pericardial Cysts and Diverticula.
Record Nr. UNINA-9910437999803321
Mazur Wojciech  
London : , : Springer London : , : Imprint : Springer, , 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Diseases of the Chest and Heart [[electronic resource] ] : Diagnostic Imaging and Interventional Techniques / / edited by Jürg Hodler, Rahel A. Kubik-Huch, Gustav K. von Schulthess, Christoph Zollikofer
Diseases of the Chest and Heart [[electronic resource] ] : Diagnostic Imaging and Interventional Techniques / / edited by Jürg Hodler, Rahel A. Kubik-Huch, Gustav K. von Schulthess, Christoph Zollikofer
Edizione [1st ed. 2015.]
Pubbl/distr/stampa Milano : , : Springer Milan : , : Imprint : Springer, , 2015
Descrizione fisica 1 online resource (274 p.)
Disciplina 610
616.0757
616.12075
Soggetto topico Radiology
Interventional radiology 
Cardiac imaging
Diagnostic Radiology
Interventional Radiology
Cardiac Imaging
ISBN 88-470-5752-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto CT Diagnosis and Management of Focal Lung Disease -- Modern Diagnosis in the Evaluation of Pulmonary Vascular Disease -- Plain Film and CT Diagnosis of the Adult Mediastinum and Hilum: Pitfalls vs. Disease -- Cardiac MR -- Incidental Findings on Thoracic and Cardiac CT -- Thoracic Manifestations of Pediatric Systemic Diseases -- Plain Film and CT Diagnosis of the Adult Mediastinum and Hilum: Pitfalls vs. Disease -- Imaging of Chest Trauma -- An Integrative Approach to Imaging of Cardiac Ischemic Heart Disease -- Plain Film and HRCT Diagnosis of Interstitial Lung Disease -- Chest Manifestations of Systemic Diseases -- Modern Diagnosis in the Evaluation of Pulmonary Vascular Disease -- Current Concepts in Diagnosis and Staging of Lung Cancer -- Molecular Breast Imaging (MBI) - What the Radiologist and Senologist Should Know -- Cardiac CT in Adult Heart Disease -- Plain Film and HRCT Diagnosis of Interstitial Lung Disease -- Imaging of Pulmonary Infections -- Current Approach to Acute and Chronic Airway Disease -- Imaging of Thoracic Vascular Pathology -- Molecular Imaging for Radiation Treatment Planning -- Imaging of Pulmonary Infections -- Cardiac CT in Adult Heart Disease -- Missed Lung Lesions: Side by Side Comparison of Chest Radiography with MDCT -- Pediatric Chest Tumors Including Lymphoma -- Staging, Restaging and Response Evaluation of NSCLC.-  Current Approach to Acute and Chronic Airway Disease -- How to Deal with Incidental Findings on Lung CTs Obtained in Hybrid Imaging -- Integrated Cardiac Imaging -- Diseases of the Chest Wall, Pleura and Diaphragm -- Imaging of Chest Trauma -- Imaging of Mediastinal Masses -- A Systematic Approach to Chest X-Ray Diagnosis -- Non Mass Like Enhancement (NMLE) on Breast MRI - When to Biopsy -- Recent Developments in Breast Ultrasound with a Special Focus on Shear-Wave Elastography -- Thoracic Manifestations of Pediatric Systemic Diseases -- Pediatric Cardio-Vascular Diseases -- Modern Dose Lowering Strategies in CT Imaging of the Lung and Heart -- An Integrative Approach to Imaging of Cardiac Ischemic Heart Disease -- Interventional Radiology in the Thorax of Adults -- Children with Fever and Cough: What to Look for? -- High Resolution CT of the Pediatric Chest: Pearls and Pitfalls -- Cardiac MR -- A Systematic Approach to Chest X-Ray Diagnosis -- Imaging of Thoracic Vascular Pathology -- Chest Manifestations of Systemic Diseases.-  Modern Dose Lowering Strategies in CT Imaging of the Lung and Heart -- Cardiovascular Imaging with SPECT and PET -- Diseases of the Chest Wall, Pleura and Diaphragm -- Missed Lung Lesions: Side by Side Comparison of Chest Radiography with MDCT -- Children with Fever and Cough: What to Look for? -- Neonatal Medical and Surgical Lung Diseases -- Incidental Findings on Thoracic and Cardiac CT -- MRI of Implants and the Reconstructed Breast -- Current Concepts in Diagnosis and Staging of Lung Cancer -- CT Diagnosis and Management of Focal Lung Disease -- Interventional Radiology in the Thorax of Adults.  .
Record Nr. UNINA-9910300215803321
Milano : , : Springer Milan : , : Imprint : Springer, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hybrid cardiac imaging for clinical decision-making : from diagnosis to prognosis / / Francesco Nudi [and three others], editors
Hybrid cardiac imaging for clinical decision-making : from diagnosis to prognosis / / Francesco Nudi [and three others], editors
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2022]
Descrizione fisica 1 online resource (240 pages)
Disciplina 616.12075
Soggetto topico Heart - Diseases - Diagnosis
Heart - Imaging
ISBN 3-030-99391-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910588595203321
Cham, Switzerland : , : Springer, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Imaging of inflammation and infection in cardiovascular diseases / / edited by Federico Caobelli
Imaging of inflammation and infection in cardiovascular diseases / / edited by Federico Caobelli
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2021]
Descrizione fisica 1 online resource (274 pages)
Disciplina 616.12075
Soggetto topico Heart - Imaging
Heart - Infections
Malalties cardiovasculars
Malalties del cor
Diagnòstic per la imatge
Infeccions
Inflamació
Soggetto genere / forma Llibres electrònics
ISBN 3-030-81131-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Preface -- Contents -- Part I: Challenges in Patient Preparation -- 1: Challenges in Patient Preparation -- 1.1 Introduction -- 1.2 Prolonged Intervals of Fasting -- 1.3 Dietary Modifications -- 1.4 Pharmacologic Approaches -- 1.5 Conclusion -- References -- Part II: Non-ischemic Diseases -- 2: Cardiac Sarcoidosis -- 2.1 Introduction -- 2.2 Screening for Cardiac Sarcoidosis -- 2.3 Diagnosis -- 2.4 Endomyocardial Biopsy: Imaging Guidance -- 2.5 CMR for Diagnosis/CMR Imaging Protocol -- 2.6 Late Gadolinium Enhancement (LGE) -- 2.7 Imaging Myocardial Inflammation and Quantitative Tissue Characterization with CMR T1 and T2 Mapping -- 2.8 Additional CMR Findings Suggestive of Cardiac Sarcoidosis -- 2.9 Differential Diagnosis -- 2.10 Treatment: Anti-Inflammatory Therapy -- 2.11 CMR for Arrhythmogenic Risk Stratification/ICD -- 2.12 Positron Emission Tomography -- 2.13 Positron Emission Tomography with Tracers Other than 18F-FDG -- 2.14 Prognosis -- 2.15 Follow-up and Monitoring of Anti-Inflammatory Response -- 2.16 Hybrid PET-CMR Imaging -- 2.17 Outlook -- 2.18 Conclusion -- References -- 3: Cardiac Amyloidosis -- 3.1 Introduction -- 3.1.1 Different Phenotypes of Cardiac Amyloidosis -- 3.1.1.1 AL Amyloidosis -- 3.1.1.2 ATTR Amyloidosis -- 3.1.2 Screening for Cardiac Amyloidosis -- 3.2 Diagnosis -- 3.2.1 Endomyocardial Biopsy -- 3.2.2 Cardiac Magnetic Resonance (CMR) Imaging -- 3.2.2.1 CMR Diagnosis and Imaging Protocol -- 3.2.2.2 Late Gadolinium Enhancement (LGE) -- 3.2.2.3 Quantitative Tissue Characterization with CMR Native T1, T2 and ECV Mapping -- 3.2.2.4 Differential Diagnosis of AL vs. ATTR Amyloid -- 3.2.3 Scintigraphy -- 3.2.3.1 Bone Avid Radiotracers -- Imaging Protocols and Interpretation -- Diagnostic Accuracy -- 3.2.3.2 Innervation Radiotracers -- 3.2.4 Positron Emission Tomography (PET).
3.2.5 Hybrid Imaging: PET/MRI -- 3.2.6 Diagnostic Algorithm for Diagnosis and Sub-Typing of Cardiac Amyloidosis -- 3.3 Treatment -- 3.4 Prognosis -- 3.5 Conclusion -- References -- Part III: Ischemic Diseases -- 4: Molecular Imaging of Vulnerable Plaque -- 4.1 Introduction -- 4.2 Biology and Pathogenesis of Atherosclerosis -- 4.2.1 History -- 4.2.2 Mechanisms of Atherosclerosis -- 4.2.2.1 Initiation of Atherosclerosis -- Vascular Endothelium and Atherosclerosis -- Hemodynamics Forces in Atherosclerosis -- Low-Density Lipoprotein Cholesterol -- Surface Adhesion Molecules -- Foam Cells Formation -- Progression of Atherosclerosis -- Smooth Muscle Cells and Atherosclerosis -- Calcification -- Plaque Neoangiogenesis -- Innate Immunity Cells in Atherosclerosis -- Adaptive Immunity in Atherosclerosis -- 4.2.3 Complication of Atherosclerosis -- 4.2.3.1 Inducible Ischemia -- 4.2.3.2 Plaque Rupture -- 4.2.3.3 Plaque Erosion -- 4.3 Metabolism of Glucose in Atherosclerosis -- 4.3.1 Glucose and Immune Cells -- 4.3.2 Imaging Inflammation in Atherosclerosis Using Glucose Metabolism -- 4.4 Targeting Chemokine Receptor Expression in Vulnerable Plaque -- 4.4.1 Technological Advancements: PET/MRI and Chemokine Receptor -- 4.4.2 Radiopharmaceutical Agents Advancements: Theragnostic and Chemochine Receptor -- 4.5 Targeting Microcalcification in Atherosclerosis -- 4.5.1 Atherosclerotic Plaque Calcium Deposition -- 4.5.2 Cardiovascular Risk Quantification -- 4.5.3 High/Risk Coronary Plaque Evaluation -- 4.5.4 Atherosclerotic Plaque Composition/Activity Assessment -- 4.6 Targeting Neovascularization in Atherosclerosis -- 4.7 Targeting SSRT-2 Receptor Expression in Atherosclerosis with DOTA-Derivatives-PET -- 4.8 Summary -- References -- 5: Post-Infarction Inflammatory Alterations -- 5.1 General Introduction.
5.2 Biology of Ventricular Remodeling -- 5.2.1 Pathobiology of Ventricular Remodeling Post-MI -- 5.2.2 The Inflammatory Response -- 5.2.2.1 Resident Inflammatory Cells -- Mast Cells -- Macrophages -- 5.2.2.2 Infiltrating Inflammatory Cells -- Polymorphonuclear Leukocytes -- Monocytes and Macrophages -- Dendritic Cells -- T and B Lymphocytes -- 5.2.2.3 Cardiomyocytes and ECM -- 5.2.3 Animal Models to Study Post-AMI Inflammation -- 5.2.3.1 Small Animal Models -- Open Chest -- Coronary Artery Ligation -- Topical Application of FeCl3 -- Closed Chest -- Isoproterenol Injection -- 5.2.3.2 Large Animal Models -- Open Chest -- Coronary Artery Ligation -- Gradual Constriction -- Hydraulic Occluder -- Topical Application of FeCl3 -- Closed Chest -- Balloon Inflation -- Embolization -- Endothelial Electrical Injury -- 5.3 The Role of Molecular Imaging -- 5.3.1 Cardiac MRI -- 5.3.2 Single-Photon Emission Computed Tomography -- 5.3.3 Positron Emission Tomography -- 5.4 Imaging Targets -- 5.4.1 Metabolic Activity -- 5.4.2 Labeled Cells -- 5.4.3 Membrane Receptors -- 5.4.4 Somatostatin Receptors -- 5.4.5 Mannose Receptor -- 5.4.6 Folate Receptor -- 5.4.7 Translocator Protein -- 5.4.8 Glucagon-like Peptide-1 Receptor (GLP-1R) -- 5.4.9 Chemokine Receptors -- 5.4.10 Lymphocyte Markers -- 5.4.10.1 Adhesion Molecules -- 5.4.10.2 Extracellular (Matrix) Components -- 5.5 Hybrid Imaging: The Added Value of Hybrid Imaging -- 5.6 Concluding Remarks -- References -- Part IV: Infection -- 6: Infection: Pericarditis -- 6.1 Pericardial Anatomy -- 6.2 Pericardial Pathologies -- 6.3 Aetiology and Pathophysiology -- 6.4 Clinical Manifestations and Diagnosis -- 6.5 Computed Tomography -- 6.6 Cardiovascular Magnetic Resonance (CMR) -- 6.6.1 Typical CMR Protocol for the Evaluation of Pericardial Disease -- 6.6.2 CMR and Acute Pericarditis.
6.6.3 CMR and Pericardial Effusions -- 6.6.4 CMR and Pericardial Constriction -- 6.6.5 Constrictive-Effusive Pericarditis -- 6.7 Molecular Imaging -- 6.8 Basics of Treatment -- 6.9 Conclusion -- References -- 7: Infection: Myocarditis -- 7.1 Introduction -- 7.2 Aetiology and Pathogenesis -- 7.3 From Acute Myocarditis to Chronic Inflammatory Cardiomyopathy and Heart Failure -- 7.4 Clinical Presentations and Diagnosis -- 7.5 Endomyocardial Biopsy -- 7.6 Cardiovascular Magnetic Resonance (CMR) -- 7.7 Infectious Inflammatory Cardiomyopathy -- 7.7.1 Idiopathic/Post-Viral Myocarditis -- 7.8 Coronavirus Disease-2019 (COVID-19) and Myocarditis -- 7.9 Non-Infectious Inflammatory Cardiomyopathy -- 7.9.1 Connective Tissue Disease -- 7.9.1.1 Systemic Lupus Erythematosus -- 7.9.1.2 Rheumatoid Arthritis -- 7.9.1.3 Systemic Sclerosis/Systemic Scleroderma -- 7.9.1.4 Behçet's Disease -- 7.9.1.5 Polyarteritis Nodosa -- 7.10 Eosinophilic Myocarditis/Endomyocardial fibrosis -- 7.10.1 EGPA -- 7.10.2 Infectious Endomyocarditis and Endomyocardial Fibrosis -- 7.10.3 Haematological -- 7.11 Drug-Induced or Toxic Myocarditis -- 7.12 Inflammatory Myositis -- 7.13 Giant Cell Myocarditis -- 7.14 Genetic Causes -- 7.15 Molecular Imaging -- 7.16 Hybrid Imaging -- 7.17 Summary -- References -- 8: Cardiac Devices Infection -- 8.1 Introduction -- 8.2 Scintigraphy in Cardiac Devices Infection -- 8.2.1 Radiolabelling of White Blood Cells with 99mTc-HMPAO or 111In-oxine -- 8.2.2 Image Acquisition -- 8.2.3 Image Interpretation -- 8.2.4 Radiolabelled WBC Scintigraphy of CIED Infection -- 8.2.5 Radiolabelled WBC Imaging of Left Ventricular Assist Devices Infection -- 8.2.6 Merits and Limitations of Radiolabelled WBC Scintigraphy in Cardiac Devices Infection: Alternative SPECT Tracers -- 8.3 FDG PET/CT Imaging of Cardiac Devices Infection.
8.3.1 Patient Preparation -- 8.3.1.1 Suppression of Myocardial FDG Uptake -- 8.3.1.2 Withdrawal of Medications -- 8.3.2 Image Acquisition and Interpretation -- 8.3.3 FDG PET/CT Imaging of CIED Infection -- 8.3.4 FDG PET/CT Imaging of LVAD Infection -- 8.3.5 FDG PET/CT for Extra-Cardiac Disease in Patients Assessed for Cardiac Devices Infection -- 8.4 Comparative Performance of Radionuclide WBC Scintigraphy and FDG PET/CT in Cardiac Devices Infection -- 8.5 Conclusion -- References -- 9: Endocarditis -- 9.1 Introduction -- 9.2 Single Photon Emission Tomography (SPECT) -- 9.2.1 67Ga-citrate Scintigraphy -- 9.2.2 Labelled Leukocytes Scintigraphy -- 9.2.3 Other SPECT Tracers -- 9.3 Positron Emission Tomography (PET) -- 9.4 Concluding Remarks -- References.
Record Nr. UNINA-9910502664303321
Cham, Switzerland : , : Springer, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrated non-invasive cardiovascular imaging : a guide for the practitioner / / IAEA
Integrated non-invasive cardiovascular imaging : a guide for the practitioner / / IAEA
Pubbl/distr/stampa Vienna, Austria : , : International Atomic Energy Agency, , [2021]
Descrizione fisica 1 online resource (268 pages)
Disciplina 616.12075
Collana Non-Serial Publications
Soggetto topico Heart - Diseases - Diagnosis
Heart - Diseases - Patients
ISBN 9789201016218
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Chapter 1INTRODUCTION -- 1.1. Background -- 1.2. Objective -- 1.3. Scope -- 1.4. Structure -- Part IFUNDAMENTALS OF NON-INVASIVE CARDIAC IMAGING -- Chapter 2NUCLEAR CARDIOLOGY:SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY -- 2.1. Hardware -- 2.2 Software -- 2.3. Hybrid SPECT-CT imaging systems -- 2.3.1. Techniques -- 2.3.2. Types of stress used in GSPECT procedures -- 2.3.3. Acquisition and interpretation of images -- 2.3.4. Reporting -- 2.4. Safety -- 2.5. Key messages -- References to Chapter 2 -- Chapter 3NUCLEAR CARDIOLOGY:POSITRON EMISSION TOMOGRAPHY -- 3.1. Basic principles -- 3.1.1. Hardware -- 3.1.2. Software -- 3.2. Cardiac PET radiotracers -- 3.2.1. 82Ru -- 3.2.2. 13N ammonia -- 3.2.3. 15O water -- 3.2.4. Flurpiridaz -- 3.2.5. 18F-FDG -- 3.3. Imaging protocols -- 3.3.1. MPI and MBF quantification -- 3.3.2. Myocardial viability and sarcoid imaging -- 3.3.3. Coronary artery calcium scoring with PET-CT -- 3.3.4. Display of PET perfusion rest-stress and perfusion-metabolism images -- 3.3.5. Elements of a comprehensive cardiac PET report -- 3.4. Key messages -- References to Chapter 3 -- Chapter 4ECHOCARDIOGRAPHY -- 4.1. Physics of echocardiography -- 4.2. 2-D and 3-D echocardiography -- 4.3. Doppler echocardiography -- 4.3.1. Spectral Doppler imaging -- 4.3.2. Tissue Doppler imaging -- 4.4. Speckle tracking echocardiography -- 4.5. Transthoracic and transoesophageal echocardiography -- 4.6. 3-D echocardiography -- 4.7. Contrast echocardiography -- 4.8. Key messages -- References to Chapter 4 -- Chapter 5CARDIAC MAGNETIC RESONANCE IMAGING -- 5.1. Basics of magnetic resonance imaging -- 5.2. Cardiac magnetic resonance -- 5.3. Blood flow evaluation using CMR -- 5.4. 4-D flow cardiac magnetic resonance -- 5.5. Safety considerations -- 5.6. Key messages -- References to Chapter 5 -- Chapter 6CARDIAC COMPUTED TOMOGRAPHY.
6.1. Basic principles -- 6.2. Computed tomography hardware and software -- 6.2.1. Minimum standards -- 6.2.2. Recent developments -- 6.2.3. Software for coronary computed tomography angiography -- 6.2.4. Software for determining the coronary artery calcium score -- 6.3. Techniques -- 6.3.1. Patient preparation -- 6.3.2. CCTA image acquisition -- 6.3.3. CCTA image analysis -- 6.4. Advanced CCT techniques -- 6.4.1. CACS image acquisition and reconstruction -- 6.4.2. CACS image analysis -- 6.4.3. Coronary artery calcification on non-dedicated imaging -- 6.4.4. Non-coronary cardiac imaging -- 6.5. Safety -- 6.5.1. Radiation dose parameters -- 6.5.2. Radiation dose of CCTA -- 6.5.3. Radiation dose risks -- 6.5.4. Iodinated contrast -- 6.5.5. Other medication -- 6.6. Key messages -- References to Chapter 6 -- Part IICLINICAL APPLICATIONS -- Chapter 7INTEGRATED NON-INVASIVE CARDIOVASCULAR IMAGING IN ROUTINE CLINICAL PRACTICE -- 7.1. Concept -- 7.2. Integrating the basics: ETT and echocardiography -- 7.2.1. Integrating with more advanced imaging using nuclear cardiology and computed tomography -- 7.2.2. Integrating basic modalities with other modalities -- 7.2.3. Key aspects for successful integration between modalities -- 7.3. Future of integrated cardiovascular imaging -- 7.4. Key messages -- References to Chapter 7 -- Chapter 8APPROPRIATE USE OF NON-INVASIVE CARDIAC IMAGING TECHNIQUES -- 8.1. Framework of appropriate imaging guidelines -- 8.2. Definition of appropriateness and application of guidelines -- 8.3. Future directions -- 8.4. Key messages -- References to Chapter 8 -- Chapter 9CURRENT EVIDENCE AND LESSONS LEARNED FROM RANDOMIZED TRIALS IN CARDIOVASCULAR IMAGING -- 9.1. Hierarchy of clinical research evidence in cardiovascular imaging -- 9.2. Evidentiary standards for quality cardiovascular imaging.
9.3. Lessons learned from observational data: Examples in nuclear cardiology -- 9.4. Defining comparative effectiveness -- 9.5. Examples of controlled clinical trials -- 9.6. Examples of comparative effectiveness trials -- 9.7. Therapeutic risk reduction: Guiding therapeutic decision making -- 9.8. Assimilating evidence into evaluation algorithms -- 9.9. Key messages -- References to Chapter 9 -- Chapter 10STABLE CORONARY ARTERY DISEASE -- 10.1. Clinical presentation -- 10.2. Risk prediction models and pre-test probability -- 10.2.1. Advantages of prediction models -- 10.2.2. Disadvantages of prediction models -- 10.3. Role of basic investigations -- 10.4. Role of non-invasive imaging in clinical decision making -- 10.5. Imaging algorithms based on clinical presentation -- 10.5.1. Investigation of suspected stable coronary artery disease -- 10.5.2. Important considerations when choosing a diagnostic test -- 10.5.3. Pre-operative risk assessment prior to non-cardiac surgery -- 10.5.4. Incidental identification of CAD on imaging performed for other reasons -- 10.6. Conclusion -- 10.7. Key messages -- References to Chapter 10 -- Chapter 11ACUTE CORONARY SYNDROMES -- 11.1. Definition of acute coronary syndrome -- 11.2. Pathophysiology of acute coronary syndrome -- 11.3. Role of non-invasive imaging in acute coronary syndrome -- 11.4. Clinical utility of non-invasive imaging in acute coronary syndrome -- 11.4.1. Echocardiography -- 11.4.2. Coronary computed tomography angiography -- 11.4.3. Cardiac magnetic resonance imaging -- 11.4.4. Radionuclide imaging: SPECT and PET -- 11.5. Case based approach to imaging in acute coronary syndromes -- 11.5.1. Suspected ACS: Case 1 -- 11.5.2. Suspected ACS: Case 2 -- 11.5.3. NSTE-ACS: Case 3 -- 11.5.4. STE-ACS: Case 4 -- 11.5.5. STE-ACS: Case 5 -- 11.6. Myocardial infarction with non-obstructive coronary arteries.
11.7. Key messages -- References to Chapter 11 -- Chapter 12HEART FAILURE -- 12.1. Global and regional left ventricular function -- 12.2. Left ventricular size and shape -- 12.3. Myocardial morphology and function -- 12.4. Myocardial ischaemia or viability -- 12.5. Left atrium and right ventricle -- 12.6. Valve disease -- 12.7. Key messages -- References to Chapter 12 -- Chapter 13CARDIOMYOPATHIES -- 13.1. Hypertrophic cardiomyopathy -- 13.2. Dilated cardiomyopathy -- 13.3. Restrictive cardiomyopathy -- 13.4. Specific cardiomyopathies -- 13.4.1. Cardiac amyloidosis -- 13.4.2. Cardiac sarcoidosis -- 13.4.3. Anderson-Fabry disease -- 13.5. Classification of cardiomyopathies according to left ventricular systolic or diastolic dysfunction -- 13.6. Key messages -- References to Chapter 13 -- Chapter 14PERICARDIAL DISEASES -- 14.1. Acute pericarditis -- 14.1.1. Definition and clinical presentation -- 14.1.2. Imaging algorithms and modalities for acute pericarditis based on clinical presentation -- 14.2. Cardiac tamponade -- 14.2.1. Cardiac computed tomography -- 14.2.2. Cardiac magnetic resonance -- 14.3. Constrictive pericarditis -- 14.3.1. Definition and clinical presentation -- 14.3.2. Imaging modalities for constrictive pericarditis -- 14.4. Key messages -- References to Chapter 14 -- Chapter 15PRIMARY VALVE DISEASES -- 15.1. Causes of valve disease -- 15.2. Signs, symptoms and diagnosis of valvular heart disease -- 15.3. Classification of the severity of primary valvular pathologies -- 15.4. Pre-operative imaging evaluations in patients with rheumatic mitral stenosis -- 15.5. Role of CMR imaging in patients with primary valve disease -- 15.6. Assessment of coronary anatomy in patients with primary valvular heart disease prior to surgical interventions -- 15.7. Follow-up of patients with prosthetic valves.
15.8. Role of imaging in planning percutaneous interventions for aortic stenosis -- 15.9. Role of nuclear cardiology in patients with primary valve disease -- 15.10. Follow-up and treatment of patients with advanced valvular heart disease -- 15.11. Case presentation -- 15.12. Key messages -- References to Chapter 15 -- Chapter 16CARDIO-ONCOLOGY -- 16.1. Definition -- 16.2. Clinical presentations -- 16.2.1. Asymptomatic left ventricular dysfunction -- 16.2.2. Heart failure -- 16.2.3. Vascular disease -- 16.2.4. Pericardial disease -- 16.2.5. Valvular complications -- 16.3. Imaging algorithms based on clinical presentation -- 16.4. Selection of an imaging modality -- 16.5. Echocardiography -- 16.6. Nuclear imaging -- 16.7. Cardiac magnetic resonance imaging -- 16.8. Key messages -- References to Chapter 16 -- Chapter 17ADULT CONGENITAL HEART DISEASE -- 17.1. Guidelines -- 17.2. Clinical presentation -- 17.3. Imaging modalities -- 17.4. Specific disease entities -- 17.4.1. Atrial septal defect -- 17.4.2. Ventricular septal defect -- 17.4.3. Atrioventricular septal defect -- 17.4.4. Patent ductus arteriosus -- 17.4.5. Left sided heart obstructive lesions (aortic valve disease, coarctation of aorta) -- 17.4.6. Right ventricular outflow tract obstruction (pulmonary stenosis) -- 17.4.7. Coronary artery abnormalities -- 17.4.8. Pulmonary hypertension and Eisenmenger's syndrome -- 17.4.9. Tetralogy of Fallot -- 17.4.10. Dextrotransposition of the great arteries -- 17.4.11. Congenitally corrected transposition of the great arteries -- 17.4.12. Ebstein's anomaly -- 17.4.13. Single ventricle diseases -- 17.5. Key messages -- References to Chapter 17 -- Chapter 18ENDOCARDITIS -- 18.1. Epidemiology and clinical presentation -- 18.2. Diagnostic imaging -- 18.3. Echocardiography -- 18.4. Multislice gated cardiac computed tomography.
18.5. Cardiac magnetic resonance.
Record Nr. UNINA-9910795725703321
Vienna, Austria : , : International Atomic Energy Agency, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrated non-invasive cardiovascular imaging : a guide for the practitioner / / IAEA
Integrated non-invasive cardiovascular imaging : a guide for the practitioner / / IAEA
Pubbl/distr/stampa Vienna, Austria : , : International Atomic Energy Agency, , [2021]
Descrizione fisica 1 online resource (268 pages)
Disciplina 616.12075
Collana Non-Serial Publications
Soggetto topico Heart - Diseases - Diagnosis
Heart - Diseases - Patients
ISBN 9789201016218
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Chapter 1INTRODUCTION -- 1.1. Background -- 1.2. Objective -- 1.3. Scope -- 1.4. Structure -- Part IFUNDAMENTALS OF NON-INVASIVE CARDIAC IMAGING -- Chapter 2NUCLEAR CARDIOLOGY:SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY -- 2.1. Hardware -- 2.2 Software -- 2.3. Hybrid SPECT-CT imaging systems -- 2.3.1. Techniques -- 2.3.2. Types of stress used in GSPECT procedures -- 2.3.3. Acquisition and interpretation of images -- 2.3.4. Reporting -- 2.4. Safety -- 2.5. Key messages -- References to Chapter 2 -- Chapter 3NUCLEAR CARDIOLOGY:POSITRON EMISSION TOMOGRAPHY -- 3.1. Basic principles -- 3.1.1. Hardware -- 3.1.2. Software -- 3.2. Cardiac PET radiotracers -- 3.2.1. 82Ru -- 3.2.2. 13N ammonia -- 3.2.3. 15O water -- 3.2.4. Flurpiridaz -- 3.2.5. 18F-FDG -- 3.3. Imaging protocols -- 3.3.1. MPI and MBF quantification -- 3.3.2. Myocardial viability and sarcoid imaging -- 3.3.3. Coronary artery calcium scoring with PET-CT -- 3.3.4. Display of PET perfusion rest-stress and perfusion-metabolism images -- 3.3.5. Elements of a comprehensive cardiac PET report -- 3.4. Key messages -- References to Chapter 3 -- Chapter 4ECHOCARDIOGRAPHY -- 4.1. Physics of echocardiography -- 4.2. 2-D and 3-D echocardiography -- 4.3. Doppler echocardiography -- 4.3.1. Spectral Doppler imaging -- 4.3.2. Tissue Doppler imaging -- 4.4. Speckle tracking echocardiography -- 4.5. Transthoracic and transoesophageal echocardiography -- 4.6. 3-D echocardiography -- 4.7. Contrast echocardiography -- 4.8. Key messages -- References to Chapter 4 -- Chapter 5CARDIAC MAGNETIC RESONANCE IMAGING -- 5.1. Basics of magnetic resonance imaging -- 5.2. Cardiac magnetic resonance -- 5.3. Blood flow evaluation using CMR -- 5.4. 4-D flow cardiac magnetic resonance -- 5.5. Safety considerations -- 5.6. Key messages -- References to Chapter 5 -- Chapter 6CARDIAC COMPUTED TOMOGRAPHY.
6.1. Basic principles -- 6.2. Computed tomography hardware and software -- 6.2.1. Minimum standards -- 6.2.2. Recent developments -- 6.2.3. Software for coronary computed tomography angiography -- 6.2.4. Software for determining the coronary artery calcium score -- 6.3. Techniques -- 6.3.1. Patient preparation -- 6.3.2. CCTA image acquisition -- 6.3.3. CCTA image analysis -- 6.4. Advanced CCT techniques -- 6.4.1. CACS image acquisition and reconstruction -- 6.4.2. CACS image analysis -- 6.4.3. Coronary artery calcification on non-dedicated imaging -- 6.4.4. Non-coronary cardiac imaging -- 6.5. Safety -- 6.5.1. Radiation dose parameters -- 6.5.2. Radiation dose of CCTA -- 6.5.3. Radiation dose risks -- 6.5.4. Iodinated contrast -- 6.5.5. Other medication -- 6.6. Key messages -- References to Chapter 6 -- Part IICLINICAL APPLICATIONS -- Chapter 7INTEGRATED NON-INVASIVE CARDIOVASCULAR IMAGING IN ROUTINE CLINICAL PRACTICE -- 7.1. Concept -- 7.2. Integrating the basics: ETT and echocardiography -- 7.2.1. Integrating with more advanced imaging using nuclear cardiology and computed tomography -- 7.2.2. Integrating basic modalities with other modalities -- 7.2.3. Key aspects for successful integration between modalities -- 7.3. Future of integrated cardiovascular imaging -- 7.4. Key messages -- References to Chapter 7 -- Chapter 8APPROPRIATE USE OF NON-INVASIVE CARDIAC IMAGING TECHNIQUES -- 8.1. Framework of appropriate imaging guidelines -- 8.2. Definition of appropriateness and application of guidelines -- 8.3. Future directions -- 8.4. Key messages -- References to Chapter 8 -- Chapter 9CURRENT EVIDENCE AND LESSONS LEARNED FROM RANDOMIZED TRIALS IN CARDIOVASCULAR IMAGING -- 9.1. Hierarchy of clinical research evidence in cardiovascular imaging -- 9.2. Evidentiary standards for quality cardiovascular imaging.
9.3. Lessons learned from observational data: Examples in nuclear cardiology -- 9.4. Defining comparative effectiveness -- 9.5. Examples of controlled clinical trials -- 9.6. Examples of comparative effectiveness trials -- 9.7. Therapeutic risk reduction: Guiding therapeutic decision making -- 9.8. Assimilating evidence into evaluation algorithms -- 9.9. Key messages -- References to Chapter 9 -- Chapter 10STABLE CORONARY ARTERY DISEASE -- 10.1. Clinical presentation -- 10.2. Risk prediction models and pre-test probability -- 10.2.1. Advantages of prediction models -- 10.2.2. Disadvantages of prediction models -- 10.3. Role of basic investigations -- 10.4. Role of non-invasive imaging in clinical decision making -- 10.5. Imaging algorithms based on clinical presentation -- 10.5.1. Investigation of suspected stable coronary artery disease -- 10.5.2. Important considerations when choosing a diagnostic test -- 10.5.3. Pre-operative risk assessment prior to non-cardiac surgery -- 10.5.4. Incidental identification of CAD on imaging performed for other reasons -- 10.6. Conclusion -- 10.7. Key messages -- References to Chapter 10 -- Chapter 11ACUTE CORONARY SYNDROMES -- 11.1. Definition of acute coronary syndrome -- 11.2. Pathophysiology of acute coronary syndrome -- 11.3. Role of non-invasive imaging in acute coronary syndrome -- 11.4. Clinical utility of non-invasive imaging in acute coronary syndrome -- 11.4.1. Echocardiography -- 11.4.2. Coronary computed tomography angiography -- 11.4.3. Cardiac magnetic resonance imaging -- 11.4.4. Radionuclide imaging: SPECT and PET -- 11.5. Case based approach to imaging in acute coronary syndromes -- 11.5.1. Suspected ACS: Case 1 -- 11.5.2. Suspected ACS: Case 2 -- 11.5.3. NSTE-ACS: Case 3 -- 11.5.4. STE-ACS: Case 4 -- 11.5.5. STE-ACS: Case 5 -- 11.6. Myocardial infarction with non-obstructive coronary arteries.
11.7. Key messages -- References to Chapter 11 -- Chapter 12HEART FAILURE -- 12.1. Global and regional left ventricular function -- 12.2. Left ventricular size and shape -- 12.3. Myocardial morphology and function -- 12.4. Myocardial ischaemia or viability -- 12.5. Left atrium and right ventricle -- 12.6. Valve disease -- 12.7. Key messages -- References to Chapter 12 -- Chapter 13CARDIOMYOPATHIES -- 13.1. Hypertrophic cardiomyopathy -- 13.2. Dilated cardiomyopathy -- 13.3. Restrictive cardiomyopathy -- 13.4. Specific cardiomyopathies -- 13.4.1. Cardiac amyloidosis -- 13.4.2. Cardiac sarcoidosis -- 13.4.3. Anderson-Fabry disease -- 13.5. Classification of cardiomyopathies according to left ventricular systolic or diastolic dysfunction -- 13.6. Key messages -- References to Chapter 13 -- Chapter 14PERICARDIAL DISEASES -- 14.1. Acute pericarditis -- 14.1.1. Definition and clinical presentation -- 14.1.2. Imaging algorithms and modalities for acute pericarditis based on clinical presentation -- 14.2. Cardiac tamponade -- 14.2.1. Cardiac computed tomography -- 14.2.2. Cardiac magnetic resonance -- 14.3. Constrictive pericarditis -- 14.3.1. Definition and clinical presentation -- 14.3.2. Imaging modalities for constrictive pericarditis -- 14.4. Key messages -- References to Chapter 14 -- Chapter 15PRIMARY VALVE DISEASES -- 15.1. Causes of valve disease -- 15.2. Signs, symptoms and diagnosis of valvular heart disease -- 15.3. Classification of the severity of primary valvular pathologies -- 15.4. Pre-operative imaging evaluations in patients with rheumatic mitral stenosis -- 15.5. Role of CMR imaging in patients with primary valve disease -- 15.6. Assessment of coronary anatomy in patients with primary valvular heart disease prior to surgical interventions -- 15.7. Follow-up of patients with prosthetic valves.
15.8. Role of imaging in planning percutaneous interventions for aortic stenosis -- 15.9. Role of nuclear cardiology in patients with primary valve disease -- 15.10. Follow-up and treatment of patients with advanced valvular heart disease -- 15.11. Case presentation -- 15.12. Key messages -- References to Chapter 15 -- Chapter 16CARDIO-ONCOLOGY -- 16.1. Definition -- 16.2. Clinical presentations -- 16.2.1. Asymptomatic left ventricular dysfunction -- 16.2.2. Heart failure -- 16.2.3. Vascular disease -- 16.2.4. Pericardial disease -- 16.2.5. Valvular complications -- 16.3. Imaging algorithms based on clinical presentation -- 16.4. Selection of an imaging modality -- 16.5. Echocardiography -- 16.6. Nuclear imaging -- 16.7. Cardiac magnetic resonance imaging -- 16.8. Key messages -- References to Chapter 16 -- Chapter 17ADULT CONGENITAL HEART DISEASE -- 17.1. Guidelines -- 17.2. Clinical presentation -- 17.3. Imaging modalities -- 17.4. Specific disease entities -- 17.4.1. Atrial septal defect -- 17.4.2. Ventricular septal defect -- 17.4.3. Atrioventricular septal defect -- 17.4.4. Patent ductus arteriosus -- 17.4.5. Left sided heart obstructive lesions (aortic valve disease, coarctation of aorta) -- 17.4.6. Right ventricular outflow tract obstruction (pulmonary stenosis) -- 17.4.7. Coronary artery abnormalities -- 17.4.8. Pulmonary hypertension and Eisenmenger's syndrome -- 17.4.9. Tetralogy of Fallot -- 17.4.10. Dextrotransposition of the great arteries -- 17.4.11. Congenitally corrected transposition of the great arteries -- 17.4.12. Ebstein's anomaly -- 17.4.13. Single ventricle diseases -- 17.5. Key messages -- References to Chapter 17 -- Chapter 18ENDOCARDITIS -- 18.1. Epidemiology and clinical presentation -- 18.2. Diagnostic imaging -- 18.3. Echocardiography -- 18.4. Multislice gated cardiac computed tomography.
18.5. Cardiac magnetic resonance.
Record Nr. UNINA-9910823376903321
Vienna, Austria : , : International Atomic Energy Agency, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Edizione [First edition.]
Pubbl/distr/stampa New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Descrizione fisica 1 online resource (914 pages) : illustrations
Disciplina 616.12075
Soggetto topico Heart - Diseases - Diagnosis
Soggetto genere / forma Electronic books.
ISBN 93-5250-071-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910461180503321
New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Edizione [First edition.]
Pubbl/distr/stampa New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Descrizione fisica 1 online resource (914 pages) : illustrations
Disciplina 616.12075
Soggetto topico Heart - Diseases - Diagnosis
ISBN 93-5250-071-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910797665103321
New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Manual of cardiac diagnosis / / editors, Kanu Chatterjee
Edizione [First edition.]
Pubbl/distr/stampa New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Descrizione fisica 1 online resource (914 pages) : illustrations
Disciplina 616.12075
Soggetto topico Heart - Diseases - Diagnosis
ISBN 93-5250-071-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910815537103321
New Delhi, [India] : , : Jaypee Brothers Medical Publishers (P) Ltd, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Modelling the Short QT Syndrome Gene Mutations : And Their Role in Cardiac Arrhythmogenesis / / by Ismail Adeniran
Modelling the Short QT Syndrome Gene Mutations : And Their Role in Cardiac Arrhythmogenesis / / by Ismail Adeniran
Autore Adeniran Ismail
Edizione [1st ed. 2014.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014
Descrizione fisica 1 online resource (228 p.)
Disciplina 616.12075
Collana Springer Theses, Recognizing Outstanding Ph.D. Research
Soggetto topico Systems biology
Biological systems
Cell membranes 
Statistical physics
Dynamical systems
Cardiology
Physics
Systems Biology
Membrane Biology
Complex Systems
Numerical and Computational Physics, Simulation
Statistical Physics and Dynamical Systems
ISBN 3-319-07200-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Ion Channels and the Action Potential -- Potassium Channels Implicated in the Short QT Syndrome -- The Short QT Syndrome -- Model Development -- Methods, Experimental Protocols and Mathematical Preliminaries -- Increased Vulnerability of the Human Ventricle to Re-entrant Excitation in HERG-linked SQT1 -- Mathematically Modelling the Functional Consequences of the SQT2 Mutation -- Proarrhythmia in KCNJ2-linked Short QT Syndrome: Insights from Modelling -- Relationship between Electrical and Mechanical Systole in the Short QT Syndrome: Insights from Modelling -- Discussion and Conclusion.
Record Nr. UNINA-9910300376003321
Adeniran Ismail  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui